Trademark: 97392065
Status Date
Thursday, May 2, 2024
Filing Date
Monday, May 2, 2022
Published for Opposition
Tuesday, March 7, 2023
5 Pharmaceuticals for use in the prevention and treatment of neurologic, genetic, psychologic, and psychiatric diseases and disorders
35 Promoting awareness of patient support offerings for neurologic, genetic, psychologic, and psychiatric diseases and disorders; business administrative services for medical referrals
44 Medical consulting with respect to neurologic, genetic, psychologic, and psychiatric diseases and disorders, including Rett syndrome and its identification and treatment; providing online information for health care providers, caregivers, and patients in the field of neurologic, genetic, psychologic, and psychiatric diseases and disorders; medical informational support services, namely, providing information about the benefits of diagnostic tools, medical information regarding disease diagnosis, identification, treatment, and management, and healthcare-related information to patients, caregivers, and healthcare professionals all related to neurologic, genetic, psychologic, and psychiatric diseases and disorders
42 Scientific and industrial biotechnological and biomedical research; chemical, biochemical and molecular biological analyses; medical testing in the nature of pharmaceutical testing, namely, in vitro and in vivo preclinical testing of potential drugs and consultation related thereto; providing medical and scientific research information in the field of pharmaceuticals and clinical trials
The mark consists of partially overlapping ovals of varying sizes forming a flower with the left side of the design in light purple and the right side in light blue and an overlapping oval in the middle of the left purple oval and the right blue oval that is depicted as dark purple in the middle, a lighter purple to the left, and green to the right. There is a blue circle above the flower.
The color(s) purple, green, and blue is/are claimed as a feature of the mark.
May 5, 2022
New Application Entered
May 6, 2022
New Application Office Supplied Data Entered
May 7, 2022
Notice Of Design Search Code E-Mailed
Jun 1, 2022
Assigned To Examiner
Jun 2, 2022
Non-Final Action Written
Jun 2, 2022
Non-Final Action E-Mailed
Jun 2, 2022
Notification Of Non-Final Action E-Mailed
Jun 17, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jun 17, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Jun 17, 2022
Teas Change Of Correspondence Received
Nov 30, 2022
Examiners Amendment -Written
Nov 30, 2022
Examiners Amendment E-Mailed
Nov 30, 2022
Notification Of Examiners Amendment E-Mailed
Nov 30, 2022
Examiner's Amendment Entered
Jan 24, 2023
Non-Final Action Written
Jan 24, 2023
Non-Final Action E-Mailed
Jan 24, 2023
Notification Of Non-Final Action E-Mailed
Jan 27, 2023
Examiners Amendment -Written
Jan 27, 2023
Examiners Amendment E-Mailed
Jan 27, 2023
Notification Of Examiners Amendment E-Mailed
Jan 27, 2023
Examiner's Amendment Entered
Jan 27, 2023
Approved For Pub - Principal Register
Feb 15, 2023
Notification Of Notice Of Publication E-Mailed
Mar 7, 2023
Published For Opposition
Mar 7, 2023
Official Gazette Publication Confirmation E-Mailed
May 2, 2023
Noa E-Mailed - Sou Required From Applicant
Nov 1, 2023
Sou Teas Extension Received
Nov 1, 2023
Sou Extension 1 Filed
Nov 1, 2023
Sou Extension 1 Granted
Nov 3, 2023
Notice Of Approval Of Extension Request E-Mailed
May 2, 2024
Sou Teas Extension Received
May 2, 2024
Sou Extension 2 Filed
May 2, 2024
Sou Extension 2 Granted
May 3, 2024
Notice Of Approval Of Extension Request E-Mailed
Trademark Alertz updated from USPTO on 2030-01-24
